As for grade 3–4 serious adverse events, the incidence of neutropenia was significantly higher in the short G-CSF group (p = 0.0014), while there was no significant difference in the incidence of anemia and thrombocytopenia. This evidence concerns the gene CSF3 and neutropenia.